The diagnostics sector has benefited from a few trends in the past five years that not only have the potential to transform how we screen for cancer but also detect chronic conditions— such as ...

InterVenn Biosciences, a precision diagnostics company advancing liquid biopsy with glycoproteomics, and Aranscia, a global provider of award-winning clinical workflow and diagnostic technology ...

Inflammatix has secured the FDA’s blessing for its in vitro diagnostic system, aimed at rapidly profiling the body’s response to an infectious disease at the point of care. With results in about 30 ...

Global Serological Testing Market OverviewThe global serological testing market is projected to grow at a compound annual growth rate (CAGR) of approximately 6–8% through 2027. Market expansion is ...